Jump to content

Epostane

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 17:40, 7 January 2014 ([458]Add: year, last1, first1, last2, first2, title, volume, issue, pages, journal. Formatted dashes. | Edgar181). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Epostane
Names
Other names
Win-32729
Identifiers
3D model (JSmol)
  • InChI=1S/C22H31NO3/c1-18-8-6-16-14(15(18)7-9-20(18,3)25)5-10-22-19(16,2)11-13(12-23)17(24)21(22,4)26-22/h14-16,24-25H,5-11H2,1-4H3/t14-,15-,16-,18-,19+,20-,21+,22-/m0/s1
    Key: CETKWEWBSMKADK-GSXVSZIWSA-N
  • C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@]45[C@@]3(CC(=C([C@]4(O5)C)O)C#N)C
Properties
C22H31NO3
Molar mass 357.494 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Epostane is a progestin biosynthesis inhibitor.[1]

References

  1. ^ Frye, CA; Vongher, JM (2001). "Progesterone and 3alpha,5alpha-THP enhance sexual receptivity in mice". Behavioral neuroscience. 115 (5): 1118–28. PMID 11584925.